Does TOFACITINIB Cause Inflammatory bowel disease? 85 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Inflammatory bowel disease have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
85
Reports of Inflammatory bowel disease with TOFACITINIB
0.1%
of all TOFACITINIB reports
2
Deaths
23
Hospitalizations
How Dangerous Is Inflammatory bowel disease From TOFACITINIB?
Of the 85 reports, 2 (2.4%) resulted in death, 23 (27.1%) required hospitalization, and 2 (2.4%) were considered life-threatening.
Is Inflammatory bowel disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Inflammatory bowel disease?
ISOTRETINOIN (692)
ADALIMUMAB (517)
INFLIXIMAB (444)
SECUKINUMAB (440)
VEDOLIZUMAB (271)
ACCUTANE (223)
METHOTREXATE (199)
USTEKINUMAB (166)
TACROLIMUS (160)
ETANERCEPT (135)
Which TOFACITINIB Alternatives Have Lower Inflammatory bowel disease Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN